C-RVV

C:RVV - Revive Therapeutics Ltd. - https://www.revivethera.com

18:30:50 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RVV - C	3627.0	0.01	·	0.015	1082.6	0.01			307.3	3	19	0.015 0.015 0.01	0.035 0.005	15:46:49	Oct 28	15 min RT 2¢
CSE - C	3627.0	0.01	·	0.015	1082.6	0.01			24.0	0	1	0.01 0.01 0.01	0.035 0.005	15:46:49		15 min
Omega - O						0.01			13.0		3	0.015 0.015 0.01		13:23:29		15 min
CX2 - H						0.01			91.0	1	5	0.01 0.01 0.01		13:23:33		15 min
CXD - D						0.0125	+0.0025	25.0	1.0		1	0.0125 0.0125 0.0125		11:13:50		15 min
MatchNOW - M						0.01			2.3		4			Sep 08-20		15 min
Lynx - Y						0.01			176.0	2	5	0.01 0.01 0.01		15:16:02		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 19

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:46:49	C	0.01		24,000	19 Desjardins	1 Anonymous	K
15:16:02	M	0.01		840	1 Anonymous	79 CIBC	E
15:16:02	Y	0.01		11,000	1 Anonymous	79 CIBC	K
15:16:02	Y	0.01		50,000	1 Anonymous	79 CIBC	K
15:14:31	Y	0.01		63,000	1 Anonymous	79 CIBC	K
13:26:49	M	0.01		150	7 TD Sec	79 CIBC	E
13:26:49	Y	0.01		25,000	1 Anonymous	79 CIBC	K
13:23:33	H	0.01		10,000	79 CIBC	80 National Bank	K
13:23:31	H	0.01		6,000	79 CIBC	79 CIBC	K
13:23:31	H	0.01		25,000	79 CIBC	79 CIBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2025-10-28 18:43	C:RVV	0.015	SEDAR MD & A815	SEDAR MD & A
2025-10-28 18:37	C:RVV	0.015	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2025-09-19 17:21	C:RVV	0.015	News Release200	Revive Therapeutics closes second tranche of financing
2025-09-05 19:58	C:RVV	0.02	News Release200	Revive extends $650,000 private placement
2025-08-11 19:43	C:RVV	0.02	News Release200	Revive closes $60,900 first tranche of placement
2025-07-31 02:33	C:RVV	0.015	News Release200	Revive Therapeutics arranges financing, debt settlement
2025-07-08 22:22	C:RVV	0.02	News Release200	Revive has no future plans yet with Defence R&D
2025-06-26 17:33	C:RVV	0.02	News Release200	Revive hopes to conclude bucillamine study by September
2025-06-04 16:14	C:RVV	0.03	News Release200	Revive develops new bucillamine formulation
2025-05-29 22:05	C:RVV	0.025	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-05-29 22:05	C:RVV	0.025	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-05-12 19:10	C:RVV	0.03	News Release200	Revive's bucillamine research study to end by June
2025-04-21 17:06	C:RVV	0.03	News Release200	Revive Therapeutics to settle $150,000 debt with shares
2025-04-10 13:52	C:RVV	0.02	News Release200	Revive to study bucillamine as cancer treatment
2025-04-01 16:35	C:RVV	0.015	News Release200	Revive agrees to buy Diagnamed's molecular hydrogen IP
2025-03-19 17:28	C:RVV	0.01	News Release200	Revive shareholders approve all matters at AGSM
2025-03-03 19:00	C:RVV	0.01	News Release200	Revive to buy molecular hydrogen rights from Diagnamed
2025-02-28 18:44	C:RVV	0.01	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-02-28 18:44	C:RVV	0.01	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-02-03 21:30	C:RVV	0.01	News Release200	Revive to complete Bucillamine study in February